S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 83.1 TWD 0.48%
Market Cap: 9.9B TWD

SCI Pharmtech Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Deferred Income Tax
NT$104.5m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
68%
Y
YungShin Global Holding Corp
TWSE:3705
Deferred Income Tax
NT$468m
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
12%
Formosa Laboratories Inc
TWSE:4746
Deferred Income Tax
NT$21m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
1%
ScinoPharm Taiwan Ltd
TWSE:1789
Deferred Income Tax
NT$1.3m
CAGR 3-Years
55%
CAGR 5-Years
17%
CAGR 10-Years
-8%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Deferred Income Tax
NT$1.1B
CAGR 3-Years
53%
CAGR 5-Years
45%
CAGR 10-Years
10%
Standard Chem & Pharm Co Ltd
TWSE:1720
Deferred Income Tax
NT$85.5m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
3%

SCI Pharmtech Inc
Glance View

Market Cap
9.9B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
58.86 TWD
Overvaluation 29%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Deferred Income Tax?
Deferred Income Tax
104.5m TWD

Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Deferred Income Tax amounts to 104.5m TWD.

What is SCI Pharmtech Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
68%

Over the last year, the Deferred Income Tax growth was -28%.

Back to Top